Semaglutide vs Phentermine: Key Differences

Phentermine and semaglutide get mentioned in the same breath all the time, but they aren’t the same thing and they aren’t used the same way: phentermine is a short-term appetite suppressant, and semaglutide is a weekly GLP-1 medication. They work through different mechanisms, they’re taken differently, and a clinician decides which one is appropriate for a given person.

The difference is worth understanding before you ask for either one, because each answers a different clinical situation. None of this is medical advice, and individual results vary.

How does each one work?

Phentermine is a sympathomimetic amine, which means it’s a stimulant related chemically and pharmacologically to the amphetamines, according to FDA prescribing information. It acts on the central nervous system and reduces appetite. The label itself makes an important admission: it hasn’t been established that appetite suppression is its only effect in obesity, because it also produces other central nervous system actions. It’s taken as a tablet or capsule, usually once a day before breakfast, and it’s a Schedule IV controlled substance because of its potential for abuse and dependence.

Semaglutide works in an entirely different way. It’s a GLP-1 receptor agonist, a molecule that mimics a natural gut hormone. According to the FDA label, GLP-1 is a physiological regulator of appetite and calorie intake, and its receptor sits in several areas of the brain involved in appetite regulation. When semaglutide activates that receptor, it strengthens the fullness signal, so you eat less without fighting hunger as hard. It also slows how quickly the stomach empties, so the feeling of being full lasts longer after a meal. It’s given as a once-weekly subcutaneous injection.

The core difference is this: phentermine pushes the nervous system to switch off hunger with an amphetamine-like stimulus, while semaglutide works on a hormonal pathway your body already uses to signal that you’ve had enough.

Key differences: use, duration, and route

The first practical difference is the intended length of treatment. Phentermine is FDA-approved only as a short-term adjunct (a few weeks) within a weight-reduction plan built on exercise, behavior change, and calorie restriction. The label goes further: tolerance to the appetite effect usually develops within a few weeks, and when that happens the instruction is to stop the medication, not increase the dose. Semaglutide, by contrast, is used for long-term weight management; its whole logic is to sustain the fullness signal over time, not to deliver a few-week push.

The second difference is route and rhythm. Phentermine is oral and daily; semaglutide is a weekly injection that’s stepped up gradually. Semaglutide treatment starts at a low dose and is titrated up on a schedule so the stomach can adjust and to reduce nausea; the exact steps are set by the clinician.

The third difference is the precaution profile. Because it’s a stimulant, the phentermine label warns about increases in blood pressure, insomnia if taken late in the day, and it’s contraindicated in people with a history of cardiovascular disease, uncontrolled hypertension, hyperthyroidism, glaucoma, agitated states, or a history of drug abuse. Semaglutide has its own separate set of precautions, tied mostly to the digestive system and other considerations a clinician evaluates. These aren’t interchangeable profiles, which is exactly why the choice isn’t a matter of preference but of history.

You can see how the pill format compares with the injection format in our guide to weight-loss pills vs injections, and how two GLP-1 medications compare with each other in semaglutide vs tirzepatide.

Can you combine them or switch between them?

This is one of the most common questions, and the short answer is: only under a clinician’s decision and supervision. The FDA label for phentermine explicitly states that the safety and efficacy of combining it with other weight-loss products has not been established, so combining it on your own is not a good idea. In the same way, moving from one medication to another isn’t a matter of stopping one and starting the other without guidance: each has its own onset, its own side-effect profile, and its own precautions.

The sensible path is for a professional to review your full history, your other conditions, and what you’ve already tried, and to decide from there what makes sense for you. That kind of guidance is what separates an informed decision from an experiment. If you want to explore your prescription options, you can start with our prescription weight-loss options page and talk with a clinician who can walk you through them.

The molecule behind GLP-1

To understand why semaglutide is handled differently from a stimulant, it helps to see what it actually is. It’s a GLP-1 analogue with a high degree of homology to the human hormone, and it acts as an agonist at its receptor: it binds to and activates the receptor the same way the natural GLP-1 your own gut releases after eating would.

This is semaglutide, a GLP-1 receptor agonist. Its long-acting alpha-helix structure is what lets it last about a week in the body, which is why it’s injected only once a week.

That long duration is one of the underlying reasons semaglutide is weekly rather than daily. According to the FDA label, it has a half-life of about one week and stays in circulation for several weeks after the last dose. Phentermine is the opposite on this point: it reaches its peak concentration within a few hours and clears quickly, which fits its role as a short-term push. Two molecules, two rhythms, two uses.

If you want the full picture of this hormonal pathway, we put it together in our guide to GLP-1 weight-loss injections.

Who decides which one is right for you

The honest takeaway isn’t that one is “good” and the other “bad.” They’re different tools for different situations: phentermine, a stimulant appetite suppressant meant for a few-week push; semaglutide, a GLP-1 medication meant to sustain the fullness signal over time. The right question isn’t “which is better?” but “which makes sense for my case?”, and that’s answered by a clinician who knows your history.

GLP-1 medications are FDA-approved for specific indications, and eligibility is determined by a licensed clinician. Compounded semaglutide is a non-FDA-approved preparation prepared by a state-licensed US compounding pharmacy under an individual prescription; it is not a generic and is not the same as Ozempic®. Any specific plan (which medication, what dose, for how long) is set by the person treating you.

At REMEVi, a real clinician leads your care from start to finish, with transparent pricing and no insurance runaround, so you understand every option before you decide. Talk to a real clinician at remevihealth.com.

Your Health. Your Terms.